E Estey

2.5k citations

29 papers · 1.8k indexed · h-index 15

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 15
- Acute Myeloid Leukemia Research 15
Molecular Biology 12
- Retinoids in leukemia and cellular processes 6
- Cancer therapeutics and mechanisms 3

Co-authors: Hagop M. Kantarjian (10 shared papers)Malcolm Finkelman (1 shared paper)Richard J. Ridge (1 shared paper)Paul A. Ketchum (1 shared paper)Zekaver Odabaşı (1 shared paper)Luis Ostrosky‐Zeichner (1 shared paper)Gloria Mattiuzzi (1 shared paper)John Rex (1 shared paper)
Journals: Journal of Clinical Oncology (7 papers)Blood (7 papers)Neurology (2 papers)Cancer (1 paper)British Journal of Haematology (1 paper)
Partner nations: United States United Kingdom Italy

In The Last Decade

E Estey

28 papers receiving 1.8k citations

Peers

Countries citing papers authored by E Estey

Since Specialization

Citations

This map shows the geographic impact of E Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Estey more than expected).

Fields of papers citing papers by E Estey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Estey. The network helps show where E Estey may publish in the future.

Co-authors

The 25 scholars most cited alongside E Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E Estey Line = papers co-authored together E Estey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Clinical Infectious Diseases ·Zekaver Odabaşı, Gloria Mattiuzzi, E Estey, Hagop M. Kantarjian, F. Saeki, Richard J. Ridge, Paul A. Ketchum, Malcolm Finkelman, John Rex, Luis Ostrosky‐Zeichner	2004	477
2	Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin Journal of Clinical Oncology ·Farhad Ravandi, E Estey, Dan Jones, Stefan Faderl, Susan O’Brien, Jackie Fiorentino, Sherry Pierce, Deborah Blamble, Zeev Estrov, William G. Wierda, Alessandra Ferrajoli, Srđan Verstovšek, Guillermo Garcia‐Manero, Jörge E. Cortes, Hagop M. Kantarjian	2008	270
3	DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes Journal of Clinical Oncology ·Lanlan Shen, Hagop M. Kantarjian, Yi Guo, E. Lin, Jianqin Shan, Xuelin Huang, Donald Berry, Saira Ahmed, Wei Zhu, Sherry Pierce, Yutaka Kondo, Yasuhiro Oki, Jaroslav Jelı́nek, Hussain I. Saba, E Estey, Jean‐Pierre J. Issa	2009	261
4	Therapeutic response in phase I trials of antineoplastic agents. PubMed ·E Estey, Daniel F. Hoth, Ronald Simon, Silvia Marsoni, B Leyland-Jones, R. Wittes	1986	109
5	Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. Journal of Clinical Oncology ·E Estey, Peter F. Thall, Gareth Pierce, H Kantarjian, Michael J. Keating	1997	101
6	Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. Journal of Clinical Oncology ·Meletios Α. Dimopoulos, H. Kantarjian, D. Weber, S O'brien, E Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, M Keating, Raymond Alexanian	1994	95
7	Treatment of Parkinson's Disease with Bromocriptine New England Journal of Medicine ·Abraham Lieberman, Mark J. Kupersmith, E Estey, Menek Goldstein	1976	93
8	Second cancer risk in hairy cell leukemia: analysis of 350 patients. Journal of Clinical Oncology ·Razelle Kurzrock, Sanna Ström, E Estey, S O'Brien, M Keating, Hong Jiang, Timothy E. Adams, Moshe Talpaz	1997	92
9	The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics. PubMed ·Steven M. Kornblau, Peter F. Thall, Zeev Estrov, M Walterscheid, Shilpen Patel, Alexandra Theriault, Michael J. Keating, Hagop M. Kantarjian, E Estey, Michael Andreeff	1999	72
10	The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction Blood ·KS Chang, JF Lu, G Wang, JM Trujillo, E Estey, Ann Cork, DT Chu, EJ Freireich, SA Stass	1992	62
11	Biphenotypic acute leukaemia: a case series British Journal of Haematology ·Ahmed Aribi, Carlos E. Bueso‐Ramos, E Estey, Zeev Estrov, Susan O’Brien, Francis J. Giles, Stefan Faderl, Deborah A. Thomas, Partow Kebriaei, Guillermo Garcia‐Manero, Sherry Pierce, Jörge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi	2007	40
12	Bromocriptine in Parkinson disease Neurology ·Abraham Lieberman, Mark J. Kupersmith, Govindan Gopinathan, E Estey, Albert Goodgold, Menek Goldstein	1979	32
13	NCCN Practice Guidelines for Acute Myelogenous Leukemia. PubMed ·Frederick R. Appelbaum, MR Baer, Matthew Carabasi, Steven Coutré, Harry P. Erba, E Estey, M J Glenn, Eric H. Kraut, P. Maslak, Michael Millenson, Carole B. Miller, HI Saba, Rachel Stone, M. S. Tallman, (unknown)	2000	25
14	Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia Annals of Oncology ·Norbert Vey, Hagop M. Kantarjian, Hai T. Tran, Miloslav Beran, Stephen O’Brien, Carol Bivins, Francis J. Giles, Jörge E. Cortes, Bruce D. Cheson, Susan G. Arbuck, E Estey	1999	18
15	Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. PubMed ·S M Kornblau, M. Andreeff, Shi Xue Hu, Hong-Ji Xu, Shilpen Patel, Alexandra Theriault, Charles Koller, Hagop M. Kantarjian, E Estey, A Deisseroth, William F. Benedict	1998	15
16	Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia Leukemia Research ·LaBaron T. Washington, Iman Jilani, E Estey, Maher Albitar	2002	9
17	Decitabine low-dose schedule (100 mg/m²/course) in myelodysplastic syndrome (MDS). Comparison of 3 different dose schedules Journal of Clinical Oncology ·Stephen J. O’Brien, Jean‐Pierre J. Issa, Farhad Ravandi‐Kashani, Francis J. Giles, Stefan Faderl, G. García-Manero, Jan Davis, E Estey, Hagop M. Kantarjian	2005	8
18	Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions Blood ·Varsha Gandhi, E Estey, MJ Keating, Antoine Chucrallah, W. Plunkett	1996	8
19	Modulation of angiogenesis in patients with myelodysplastic syndrome Best Practice & Research Clinical Haematology ·E Estey	2004	7
20	Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors Blood ·Zeev Estrov, Razelle Kurzrock, E Estey, Meir Wetzler, Alessandra Ferrajoli, David Harris, Mary Blake, JU Gutterman, Moshe Talpaz	1992	6

About E Estey

E Estey is a scholar working on Hematology, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (7 papers), Retinoids in leukemia and cellular processes (6 papers), Neutropenia and Cancer Infections (4 papers), Cancer therapeutics and mechanisms (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Hematology (777 citations), Genetics (265 citations), Infectious Diseases (425 citations), Biochemistry (113 citations) and Epidemiology (422 citations). E Estey has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Hagop M. Kantarjian, Malcolm Finkelman, Richard J. Ridge, Paul A. Ketchum, Zekaver Odabaşı, Luis Ostrosky‐Zeichner, Gloria Mattiuzzi, John Rex, Abraham Lieberman and Mark J. Kupersmith. Their work appears in journals such as Journal of Clinical Oncology, Blood, Neurology, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact